Does PEMBROLIZUMAB Cause Myositis? 596 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 596 reports of Myositis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.7% of all adverse event reports for PEMBROLIZUMAB.
596
Reports of Myositis with PEMBROLIZUMAB
0.7%
of all PEMBROLIZUMAB reports
172
Deaths
362
Hospitalizations
How Dangerous Is Myositis From PEMBROLIZUMAB?
Of the 596 reports, 172 (28.9%) resulted in death, 362 (60.7%) required hospitalization, and 108 (18.1%) were considered life-threatening.
Is Myositis Listed in the Official Label?
Yes, Myositis is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Myositis?
NIVOLUMAB (682)
ATORVASTATIN (448)
METHOTREXATE (418)
PREDNISONE (369)
RITUXIMAB (355)
ADALIMUMAB (344)
IPILIMUMAB (305)
ATEZOLIZUMAB (249)
INFLIXIMAB (249)
TOCILIZUMAB (238)
Which PEMBROLIZUMAB Alternatives Have Lower Myositis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G